tiprankstipranks
Allarity filed a Form 8-K regarding settlement agreement with SEC
PremiumThe FlyAllarity filed a Form 8-K regarding settlement agreement with SEC
1M ago
Allarity reports progress in Phase 2 stenoparib trial
Premium
The Fly
Allarity reports progress in Phase 2 stenoparib trial
4M ago
Allarity reports Q3 EPS ($7.71)
Premium
The Fly
Allarity reports Q3 EPS ($7.71)
4M ago
Allarity Therapeutics Strengthens Leadership for Cancer Programs
PremiumCompany AnnouncementsAllarity Therapeutics Strengthens Leadership for Cancer Programs
5M ago
Allarity Therapeutics Nears Regulatory Approval with Stenoparib Trial Success
Premium
Company Announcements
Allarity Therapeutics Nears Regulatory Approval with Stenoparib Trial Success
6M ago
Allarity announces two patients exceeding one year treatment with stenoparib
Premium
The Fly
Allarity announces two patients exceeding one year treatment with stenoparib
6M ago
Allarity Therapeutics Stockholders Approve Key Corporate Changes
PremiumCompany AnnouncementsAllarity Therapeutics Stockholders Approve Key Corporate Changes
6M ago
Allarity files to sell 18.53M shares of common stock for holders
Premium
The Fly
Allarity files to sell 18.53M shares of common stock for holders
6M ago
Allarity announces postponement of Annual Stockholders Meeting
Premium
The Fly
Allarity announces postponement of Annual Stockholders Meeting
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100